Shanghai Yogar Therapeutics synthesizes new apelin receptor agonists

July 21, 2026

Shanghai Yogar Therapeutics Co. Ltd. has divulged new apelin (APJ) receptor agonists potentially useful for the treatment of heart failure, pulmonary hypertension and muscle atrophy.

BioWorld Science Cardiovascular Patents

Today's news in brief

BioWorld

BioWorld briefs for July 23, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for July 21, 2026

To viral or not to viral: In vivo CAR T debates delivery tech

BioWorld

The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...

Tree in the shape of human head losing leaves

KBN-2201 reverses key features of Alzheimer’s in mice

BioWorld Science

Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.

Click chemistry drug bound to pancreatic cancer cells from mice

In vivo click ADCs could address tumor heterogeneity

BioWorld

Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...